Sort
261,768 grants matching “gene therapy”
Preclinical Studies of Vaccines for Pandemic Influenza
$2,549,552Kanta Subbarao · Niaid Extramural Activities · Z01 · FY2007 · AI
Lung Cancer Mutation Analysis
$2,549,415Paul A Bunn · University Of Colorado Denver · RC2 · FY2009 · CA
Impact of SARS-CoV-2 on the cerebrovasculature as a risk factor for VCID: Role of Wnt/beta-catenin
$2,549,080Sarah Elizabeth Lutz · University Of Illinois At Chicago · RF1 · FY2025 · NS
Studies of Populations Exposed to Environmental Sources of Radiation
$2,548,995Elizabeth Cahoon · Division Of Cancer Epidemiology And Genetics · ZIA · FY2025 · CA
Kit Inhibition in Asthma (KIA)
$2,548,859Elliot Israel · Brigham And Women'S Hospital · U01 · FY2012 · HL
UNIVERSITY OF MASSACHUSETTS CENTER FOR CLINICAL AND TRANSLATIONAL SCIENCE
$2,548,244John L Sullivan · Univ Of Massachusetts Med Sch Worcester · UL1 · FY2010 · RR
Molecular Genetics of Vascular Disease
$2,548,161Elizabeth G Nabel · National Human Genome Research Institute · ZIA · FY2009 · HG
Costimulatory Mechanisms of Autoimmunity
$2,548,048David A. Hafler · Yale University · P01 · FY2023 · AI
Psychotherapy Development Research Center
$2,547,438Kathleen M Carroll · Yale University · P50 · FY2014 · DA
Metabolic determinants of Mtb virulence, vulnerability and variation
$2,547,329David Branch Moody · Brigham And Women'S Hospital · U19 · FY2021 · AI
Weill Cornell Program of Excellence in Gene Therapy
$2,545,982Weill Medical College Of Cornell Univ · U01 · FY2005 · HL
Novel Therapies for Muco-Obstructive Lung Diseases
$2,545,908Richard C Boucher · Univ Of North Carolina Chapel Hill · P01 · FY2012 · HL
Molecular And Pharmacological Studies Of Dopamine Receptors
$2,545,763David Sibley · National Institute Of Neurological Disorders And Stroke · ZIA · FY2023 · NS
Systems Biology of Tumor Progression and Drug-Resistance
$2,545,749Andrea Califano · Columbia University Health Sciences · RC2 · FY2009 · CA
BREAST CANCER, RADIATION EXPOSURE, AND THE ATM GENE
$2,545,284Mount Sinai School Of Medicine Of Nyu · U01 · FY2002 · CA
Precision Medicine of Cancer
$2,545,004Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
An ultra-long-acting oral treatment for opioid use disorder
$2,543,976Andrew Martin Bellinger · Lyndra Therapeutics, Inc. · UG3 · FY2018 · DA
North Central Cancer Treatment Group
$2,543,699Jan C Buckner · Mayo Clinic Rochester · U10 · FY2007 · CA
Toward Safer Gene Therapy for Hemophilia A
$2,542,930Roland W. Herzog · Indiana University Indianapolis · P01 · FY2023 · HL
Toward Safer Gene Therapy for Hemophilia A
$2,542,930Roland W. Herzog · Indiana University Indianapolis · P01 · FY2025 · HL
Towards a molecular understanding of persistent tuberculosis infection
$2,542,500Jeremy Michael Rock · Rockefeller University · DP2 · FY2018 · AI
Dissecting tumor metabolic heterogeneity in vivo
$2,542,500Kivanc Birsoy · Rockefeller University · DP2 · FY2017 · CA
Defining the role of chromatin architecture in cell fate inheritance
$2,542,500Effie Apostolou · Weill Medical Coll Of Cornell Univ · DP2 · FY2016 · DA
Experimental Therapy for Brain Tumors
$2,542,342John H Sampson · Duke University · P01 · FY2021 · CA
Center for Genetic Studies of Drug Abuse in Outbred Rats
$2,541,203Abraham A Palmer · University Of California, San Diego · P50 · FY2023 · DA